These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10665340)

  • 1. Role of protein tyrosine phosphatase-1B in diabetes and obesity.
    Kennedy BP
    Biomed Pharmacother; 1999 Dec; 53(10):466-70. PubMed ID: 10665340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase-1B in diabetes.
    Kennedy BP; Ramachandran C
    Biochem Pharmacol; 2000 Oct; 60(7):877-83. PubMed ID: 10974195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of phosphotyrosine phosphatase (PTPase) 1B in insulin signalling.
    Worm D; Vinten J; Beck-Nielsen H
    Diabetologia; 1999 Sep; 42(9):1146-9. PubMed ID: 10447528
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of protein tyrosine phosphatase (PTP-1B) in insulin resistance].
    Boduła A; Wdowczyk M; Adamiec R
    Postepy Hig Med Dosw (Online); 2005 May; 59():203-7. PubMed ID: 15928604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus.
    Cheung A; Kusari J; Jansen D; Bandyopadhyay D; Kusari A; Bryer-Ash M
    J Lab Clin Med; 1999 Aug; 134(2):115-23. PubMed ID: 10444024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.
    Elchebly M; Payette P; Michaliszyn E; Cromlish W; Collins S; Loy AL; Normandin D; Cheng A; Himms-Hagen J; Chan CC; Ramachandran C; Gresser MJ; Tremblay ML; Kennedy BP
    Science; 1999 Mar; 283(5407):1544-8. PubMed ID: 10066179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase 1B: a novel target for type 2 diabetes and obesity.
    Ramachandran C; Kennedy BP
    Curr Top Med Chem; 2003; 3(7):749-57. PubMed ID: 12678842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does inhibition of tyrosine phosphatase 1B protect from obesity and type 2 diabetes?].
    Ukkola O; Santaniemi M
    Duodecim; 2002; 118(18):1857-62. PubMed ID: 12422667
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer.
    Dubé N; Tremblay ML
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):108-17. PubMed ID: 16198645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
    Ahmad F; Azevedo JL; Cortright R; Dohm GL; Goldstein BJ
    J Clin Invest; 1997 Jul; 100(2):449-58. PubMed ID: 9218523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Single nucleotide polymorphism of protein tyrosine phosphatase 1B (PTP-1B) gene. Clinical implications in type 2 diabetes].
    Boduła A; Wdowczyk M; Adamiec R
    Pol Arch Med Wewn; 2005 Sep; 114(3):891-900. PubMed ID: 16708565
    [No Abstract]   [Full Text] [Related]  

  • 12. A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro.
    Echwald SM; Bach H; Vestergaard H; Richelsen B; Kristensen K; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
    Diabetes; 2002 Jan; 51(1):1-6. PubMed ID: 11756316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
    Zhang ZY; Lee SY
    Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in protein tyrosine phosphatase 1B inhibitors.
    Taylor SD; Hill B
    Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus.
    Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
    Med Res Rev; 2012 May; 32(3):459-517. PubMed ID: 20814956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase 1B is impaired in skeletal muscle of diabetic Psammomys obesus.
    Ikeda Y; Ziv E; Shafrir E; Mosthaf-Seedorf L
    Int J Exp Diabetes Res; 2002; 3(3):205-12. PubMed ID: 12458663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.
    Ahmad F; Goldstein BJ
    Metabolism; 1995 Sep; 44(9):1175-84. PubMed ID: 7666792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
    Liu G; Trevillyan JM
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine phosphatase 1B inhibitors for diabetes.
    Johnson TO; Ermolieff J; Jirousek MR
    Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.